Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - HARROW HEALTH, INC. | a55620e10vk.htm |
| EX-31.1 - EX-31.1 - HARROW HEALTH, INC. | a55620exv31w1.htm |
| EX-23.1 - EX-23.1 - HARROW HEALTH, INC. | a55620exv23w1.htm |
| EX-10.21 - EX-10.21 - HARROW HEALTH, INC. | a55620exv10w21.htm |
Exhibit 32
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, John Lomoro, Acting Chief Executive Officer and Chief Financial Officer of Transdel
Pharmaceuticals, Inc. (the “Company”) certify under the standards set forth and solely for the
purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that, to my knowledge:
| (1) | The Annual Report on Form 10-K of the Company for the fiscal year ended December 31, 2009 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 as amended; and | ||
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: March 31, 2010
| /s/ John Lomoro | ||||
| John Lomoro, Acting Chief Executive Officer and Chief | ||||
| Financial Officer | ||||
This certification accompanies each Report pursuant to § 906 of the Sarbanes-Oxley Act of 2002
and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by
the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.
A signed original of this written statement required by Section 906 has been provided to the
Company and will be retained by the Company and furnished to the Securities and Exchange Commission
or its staff upon request.